JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bylund, D. B.
Right arrow Articles by Chacko, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bylund, D. B.
Right arrow Articles by Chacko, D. M.

Vol. 281, Issue 3, 1171-1177, 1997

Characterization of Alpha-2D Adrenergic Receptor Subtypes in Bovine Ocular Tissue Homogenates

David B. Bylund, Laurie J. Iversen, William J. Matulka and David M. Chacko

Departments of Pharmacology (D.B.B., L.J.I., W.J.M.) and Ophthalmology (D.M.C.), University of Nebraska Medical Center, Omaha, Nebraska

The alpha-2 adrenergic receptors are known to be present in the mammalian eye and to mediate the effects of alpha-2 agonists used in the treatment of glaucoma. Little is known, however, regarding the relative densities of the three alpha-2 subtypes in the various tissues of the eye. We used receptor binding experiments with the radioligand [3H]RX821002 to characterize the alpha-2 adrenergic receptors in three tissues of the bovine eye, the ciliary body, retinal pigment epithelium/choriocapillaris and iris. The KD values in the three tissues were similar (0.12-0.14 nM), and the Bmax values ranged from 100 fmol/mg of protein for the ciliary body and retinal pigment epithelium/choriocapillaris to 200 fmol/mg of protein for the iris. The pharmacological characteristics of the alpha-2 receptors in all three tissues of the bovine eye, as assessed by competition studies, were essentially identical and were similar to the characteristics of the alpha-2A/D receptors of the bovine neurosensory retina. The correlation coefficients between the logarithms of the Ki values for the three tissues and the neurosensory retina for nine adrenergic agents were .98 to .99. We conclude that the alpha-2 adrenergic receptors in the ciliary body, iris and retinal pigment epithelium/choriocapillaris of the bovine eye are mainly alpha-2D.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
IOVSHome page
A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern
Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Wikberg-Matsson and U. Simonsen
Potent {alpha}2A-Adrenoceptor-Mediated Vasoconstriction by Brimonidine in Porcine Ciliary Arteries
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2049 - 2055.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. P. Naselsky, D. Ashton, R. R. Ruffolo Jr., and J. P. Hieble
Rabbit alpha 2-Adrenoceptors: Both Platelets and Adipocytes Have alpha 2A-Pharmacology
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 219 - 225.
[Abstract] [Full Text]


Home page
IOVSHome page
D. B. Bylund and D. M. Chacko
Characterization of {alpha}2 Adrenergic Receptor Subtypes in Human Ocular Tissue Homogenates
Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2299 - 2306.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.